These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9795865)
1. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents. Mincione F; Menabuoni L; Briganti F; Mincione G; Scozzafava A; Supuran CT J Enzyme Inhib; 1998 Jul; 13(4):267-84. PubMed ID: 9795865 [TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: N-cyanosulfonamides, a new class of high affinity isozyme II and IV inhibitors. Supuran CT; Scozzafava A; Briganti F J Enzyme Inhib; 1999; 14(4):289-306. PubMed ID: 10445050 [TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes. Supuran CT; Scozzafava A; Saramet I; Banciu MD J Enzyme Inhib; 1998 Jun; 13(3):177-94. PubMed ID: 9629536 [TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: novel compounds containing S-NH moieties: sulfenamido-sulfonamides, sulfenimido-sulfonamides and their interaction with isozymes I, II and IV. Scozzafava A; Supuran CT J Enzyme Inhib; 1998 Sep; 13(6):419-42. PubMed ID: 9825306 [TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action. Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT J Med Chem; 2000 Nov; 43(23):4542-51. PubMed ID: 11087579 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Part 71. Synthesis and ocular pharmacology of a new class of water-soluble, topically effective intraocular pressure lowering sulfonamides incorporating picolinoyl moieties. Supuran CT; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G Eur J Pharm Sci; 1999 Aug; 8(4):317-28. PubMed ID: 10425382 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV by sulfamide and sulfamic acid derivatives. Scozzafava A; Banciu MD; Popescu A; Supuran CT J Enzyme Inhib; 2000; 15(5):443-53. PubMed ID: 11030084 [TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? Borras J; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT Bioorg Med Chem; 1999 Nov; 7(11):2397-406. PubMed ID: 10632049 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action. Bozdag M; Carta F; Vullo D; Akdemir A; Isik S; Lanzi C; Scozzafava A; Masini E; Supuran CT Bioorg Med Chem; 2015 May; 23(10):2368-76. PubMed ID: 25846066 [TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma. Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes. Scozzafava A; Supuran CT J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282 [TBL] [Abstract][Full Text] [Related]